MX2019006768A - Peptidos antimicrobianos. - Google Patents

Peptidos antimicrobianos.

Info

Publication number
MX2019006768A
MX2019006768A MX2019006768A MX2019006768A MX2019006768A MX 2019006768 A MX2019006768 A MX 2019006768A MX 2019006768 A MX2019006768 A MX 2019006768A MX 2019006768 A MX2019006768 A MX 2019006768A MX 2019006768 A MX2019006768 A MX 2019006768A
Authority
MX
Mexico
Prior art keywords
antimicrobial peptides
formula
compounds
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
MX2019006768A
Other languages
English (en)
Inventor
Henninot Antoine
William Carney Daniel
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX2019006768A publication Critical patent/MX2019006768A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Esta descripción se refiere a compuestos de la fórmula (I) o una sal farmacéuticamente aceptable de los mismos: Fórmula (I), en la cual n, R1, R1', R2, R3, R4, R4' y R5-R14 se definen en la especificación. Los compuestos de la fórmula (I) se pueden usar para tratar una infección bacteriana.
MX2019006768A 2016-12-13 2017-12-13 Peptidos antimicrobianos. MX2019006768A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662433567P 2016-12-13 2016-12-13
PCT/EP2017/082697 WO2018109042A2 (en) 2016-12-13 2017-12-13 Antimicrobial peptides

Publications (1)

Publication Number Publication Date
MX2019006768A true MX2019006768A (es) 2019-08-01

Family

ID=60788591

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006768A MX2019006768A (es) 2016-12-13 2017-12-13 Peptidos antimicrobianos.

Country Status (13)

Country Link
US (1) US20200216493A1 (es)
EP (1) EP3554528A2 (es)
JP (1) JP2020500943A (es)
KR (1) KR20190093600A (es)
CN (1) CN110072539A (es)
AR (1) AR110514A1 (es)
AU (1) AU2017375034A1 (es)
BR (1) BR112019011010A2 (es)
CA (1) CA3047043A1 (es)
MX (1) MX2019006768A (es)
RU (1) RU2019120181A (es)
TW (1) TW201827415A (es)
WO (1) WO2018109042A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3443078A4 (en) * 2016-04-15 2020-04-15 The Regents of The University of California ANTIMICROBIAL COMPOSITIONS
WO2018162922A1 (en) * 2017-03-09 2018-09-13 University Of Lincoln New antibacterial products
EP3735415A4 (en) * 2018-01-03 2022-04-27 Versitech Limited NOVEL ANTIBIOTICS AND METHODS OF USING THEM
WO2021013217A1 (en) * 2019-07-24 2021-01-28 Sunshine Lake Pharma Co., Ltd. A teixobactin analogue and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50160492A (es) * 1974-06-22 1975-12-25
GB9724859D0 (en) * 1997-11-26 1998-01-21 Univ Nottingham Compounds and their use as antibacterial agents
AU769791B2 (en) * 1998-06-24 2004-02-05 New York University Novel Staphylococcus peptides for bacterial interference
US20110039762A1 (en) * 2009-01-06 2011-02-17 C3 Jian, Inc. Targeted antimicrobial moieties
TW202400211A (zh) * 2012-12-03 2024-01-01 美商諾維生物製藥有限公司 新穎縮肽及其用途
US9605026B2 (en) * 2013-01-19 2017-03-28 New York University Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation
EP3443078A4 (en) * 2016-04-15 2020-04-15 The Regents of The University of California ANTIMICROBIAL COMPOSITIONS
CN106632604B (zh) * 2016-12-22 2021-03-19 深圳先进技术研究院 一种Teixobactin类似物及其制备方法和应用
CN107266531B (zh) * 2017-07-28 2020-04-07 北京大学深圳研究生院 Teixobactin及其制备方法

Also Published As

Publication number Publication date
CA3047043A1 (en) 2018-06-21
EP3554528A2 (en) 2019-10-23
CN110072539A (zh) 2019-07-30
WO2018109042A2 (en) 2018-06-21
US20200216493A1 (en) 2020-07-09
RU2019120181A (ru) 2021-01-18
BR112019011010A2 (pt) 2019-10-08
TW201827415A (zh) 2018-08-01
WO2018109042A3 (en) 2018-07-26
AU2017375034A1 (en) 2019-06-13
KR20190093600A (ko) 2019-08-09
JP2020500943A (ja) 2020-01-16
AR110514A1 (es) 2019-04-03

Similar Documents

Publication Publication Date Title
MX2022005290A (es) Compuestos heterociclicos como inmunomoduladores.
MX2022012317A (es) Oxisteroles y metodos de uso de los mismos.
MX2022005160A (es) Oxisteroles y metodos de uso de los mismos.
NZ733174A (en) Quinazoline derivatives used to treat hiv
GEP20186892B (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
MX2017012393A (es) Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico.
MX2017007814A (es) Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico.
AU2018253590A1 (en) Imidazopyridazine compounds
MX2015008957A (es) Fluoro-[1,3]oxazinas como inhibidores de beta-secretasa 1 (bace1).
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
NZ733125A (en) Isoquinoline compounds for the treatment of hiv
WO2015110969A3 (en) Nitrogen containing compounds and their use as antibacterial agents
MX2019006768A (es) Peptidos antimicrobianos.
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
WO2016004513A8 (en) Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods
MX2020000576A (es) Compuestos quimicos.
MX2020002824A (es) Aminas beta-hidroxi heterociclicas y su uso en el tratamiento de la hiperglucemia.
MX2017009094A (es) Derivado de polimixina y usos del mismo.
MY194711A (en) Novel annelated phenoxyacetamides
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
MX2019011908A (es) Macrociclos de peptidos anti-bacterianos y uso de los mismos.
PH12018500358A1 (en) Compounds for use in an antibacterial applications
PH12019502509A1 (en) Compounds and methods for treating bacterial infections
MX2017007955A (es) Formas solidas que comprenden (1e, 4e)-2-amino-n,n-dipropil-8-(4-( pirrolidina-1-carbonil)fenil)-3h-benzo[b]azepina-4-carboxamida, composiciones de las mismas y usos de las mismas.
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof